- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.79 Å
- Oligo State
- hetero-3-3-3-3-mer
- Ligands
- 3 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 12 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.2: 2 residues within 4Å:- Chain A: N.62, E.94
No protein-ligand interaction detected (PLIP)NAG.3: 3 residues within 4Å:- Chain A: N.133, N.162
- Chain D: I.96
2 PLIP interactions:1 interactions with chain A, 1 interactions with chain D- Hydrogen bonds: A:N.162
- Hydrophobic interactions: D:I.96
NAG.4: 3 residues within 4Å:- Chain A: N.294, S.296, L.297
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:S.296
NAG.5: 1 residues within 4Å:- Chain A: N.31
No protein-ligand interaction detected (PLIP)NAG.15: 2 residues within 4Å:- Chain E: N.62, E.94
No protein-ligand interaction detected (PLIP)NAG.16: 3 residues within 4Å:- Chain E: N.133, N.162
- Chain H: I.96
2 PLIP interactions:1 interactions with chain H, 1 interactions with chain E- Hydrophobic interactions: H:I.96
- Hydrogen bonds: E:N.162
NAG.17: 3 residues within 4Å:- Chain E: N.294, S.296, L.297
1 PLIP interactions:1 interactions with chain E- Hydrogen bonds: E:S.296
NAG.18: 1 residues within 4Å:- Chain E: N.31
No protein-ligand interaction detected (PLIP)NAG.28: 2 residues within 4Å:- Chain I: N.62, E.94
No protein-ligand interaction detected (PLIP)NAG.29: 3 residues within 4Å:- Chain I: N.133, N.162
- Chain L: I.96
2 PLIP interactions:1 interactions with chain L, 1 interactions with chain I- Hydrophobic interactions: L:I.96
- Hydrogen bonds: I:N.162
NAG.30: 3 residues within 4Å:- Chain I: N.294, S.296, L.297
1 PLIP interactions:1 interactions with chain I- Hydrogen bonds: I:S.296
NAG.31: 1 residues within 4Å:- Chain I: N.31
No protein-ligand interaction detected (PLIP)- 18 x SO4: SULFATE ION(Non-functional Binders)
SO4.6: 3 residues within 4Å:- Chain A: K.127, K.153, R.259
Ligand excluded by PLIPSO4.7: 7 residues within 4Å:- Chain A: Y.99, P.190, D.194, D.229, R.230, E.231, G.232
Ligand excluded by PLIPSO4.8: 4 residues within 4Å:- Chain A: H.200, T.201, E.202, N.203
Ligand excluded by PLIPSO4.9: 7 residues within 4Å:- Chain A: G.160, K.161, N.162, G.163, L.164, A.197, H.200
Ligand excluded by PLIPSO4.10: 3 residues within 4Å:- Chain A: F.122, E.123
- Chain C: N.104
Ligand excluded by PLIPSO4.11: 3 residues within 4Å:- Chain A: R.81, E.82, S.83
Ligand excluded by PLIPSO4.19: 3 residues within 4Å:- Chain E: K.127, K.153, R.259
Ligand excluded by PLIPSO4.20: 7 residues within 4Å:- Chain E: Y.99, P.190, D.194, D.229, R.230, E.231, G.232
Ligand excluded by PLIPSO4.21: 4 residues within 4Å:- Chain E: H.200, T.201, E.202, N.203
Ligand excluded by PLIPSO4.22: 7 residues within 4Å:- Chain E: G.160, K.161, N.162, G.163, L.164, A.197, H.200
Ligand excluded by PLIPSO4.23: 3 residues within 4Å:- Chain E: F.122, E.123
- Chain G: N.104
Ligand excluded by PLIPSO4.24: 3 residues within 4Å:- Chain E: R.81, E.82, S.83
Ligand excluded by PLIPSO4.32: 3 residues within 4Å:- Chain I: K.127, K.153, R.259
Ligand excluded by PLIPSO4.33: 7 residues within 4Å:- Chain I: Y.99, P.190, D.194, D.229, R.230, E.231, G.232
Ligand excluded by PLIPSO4.34: 4 residues within 4Å:- Chain I: H.200, T.201, E.202, N.203
Ligand excluded by PLIPSO4.35: 7 residues within 4Å:- Chain I: G.160, K.161, N.162, G.163, L.164, A.197, H.200
Ligand excluded by PLIPSO4.36: 3 residues within 4Å:- Chain I: F.122, E.123
- Chain K: N.104
Ligand excluded by PLIPSO4.37: 3 residues within 4Å:- Chain I: R.81, E.82, S.83
Ligand excluded by PLIP- 6 x GOL: GLYCEROL(Non-functional Binders)
GOL.12: 4 residues within 4Å:- Chain A: S.64, G.96, T.97, Y.106
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:S.64, A:T.97, A:Y.106
GOL.13: 4 residues within 4Å:- Chain A: G.101, H.102, F.103
- Chain E: H.212
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:F.103, A:F.103
GOL.25: 4 residues within 4Å:- Chain E: S.64, G.96, T.97, Y.106
2 PLIP interactions:2 interactions with chain E- Hydrogen bonds: E:S.64, E:T.97
GOL.26: 4 residues within 4Å:- Chain E: G.101, H.102, F.103
- Chain I: H.212
2 PLIP interactions:2 interactions with chain E- Hydrogen bonds: E:F.103, E:F.103
GOL.38: 4 residues within 4Å:- Chain I: S.64, G.96, T.97, Y.106
2 PLIP interactions:2 interactions with chain I- Hydrogen bonds: I:S.64, I:T.97
GOL.39: 4 residues within 4Å:- Chain A: H.212
- Chain I: G.101, H.102, F.103
3 PLIP interactions:3 interactions with chain I- Hydrogen bonds: I:H.102, I:F.103, I:F.103
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Raymond, D.D. et al., Conserved epitope on influenza-virus hemagglutinin head defined by a vaccine-induced antibody. Proc. Natl. Acad. Sci. U.S.A. (2018)
- Release Date
- 2017-12-20
- Peptides
- Hemagglutinin HA1: AEI
Hemagglutinin HA2: BFJ
6649 antibody heavy chain: CGK
6649 antibody light chain: DHL - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AE
AI
AB
BF
BJ
BC
HG
HK
HD
LH
LL
L
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.79 Å
- Oligo State
- hetero-3-3-3-3-mer
- Ligands
- 3 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 12 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 18 x SO4: SULFATE ION(Non-functional Binders)
- 6 x GOL: GLYCEROL(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Raymond, D.D. et al., Conserved epitope on influenza-virus hemagglutinin head defined by a vaccine-induced antibody. Proc. Natl. Acad. Sci. U.S.A. (2018)
- Release Date
- 2017-12-20
- Peptides
- Hemagglutinin HA1: AEI
Hemagglutinin HA2: BFJ
6649 antibody heavy chain: CGK
6649 antibody light chain: DHL - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AE
AI
AB
BF
BJ
BC
HG
HK
HD
LH
LL
L